Holdings
Patient Square Capital LP
As of Sep 30, 2026, Patient Square Capital LP reported 22 positions worth US$601M. Largest: Roivant Sciences Ltd., Revolution Medicines, Inc. and United Therapeutics Corporation. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Roivant Sciences Ltd. | 7.71M | US$282M | −310K | Sep 30, 2026 |
| Revolution Medicines, Inc. | 196K | US$40.2M | −80,000 | Sep 30, 2026 |
| United Therapeutics Corporation | 62,677 | US$34M | +25,557 | Sep 30, 2026 |
| argenx SE | 28,000 | US$26.8M | +5,000 | Sep 30, 2026 |
| Abivax SA | 243K | US$24.1M | +36,500 | Sep 30, 2026 |
| Belite Bio, Inc. | 132K | US$22.4M | new | Sep 30, 2026 |
| Mirum Pharmaceuticals, Inc. | 234K | US$20M | −26,500 | Sep 30, 2026 |
| Zai Lab Ltd. | 592K | US$15.6M | new | Sep 30, 2026 |
| Definium Therapeutics, Inc. | 385K | US$14.7M | new | Sep 30, 2026 |
| COMPASS Pathways Plc | 1.06M | US$13.1M | new | Sep 30, 2026 |